2m 2m 2m 2m 2m 2m 2m
VTV THERAP-A (VTVT)
NASDAQ
$31.46-$0.12 (-0.40%)
Price as of Jul 13, 2026 7:53 PM EDT- $124.4MMarket Cap
- 88.99%1-Year Change
- BiotechnologyIndustry
VTV THERAP-A (VTVT)
$31.46-$0.12 (-0.40%)
VTVT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $31.58 | ||
Change | -$1.91 (-5.70%) | ||
Open | $33.40 | ||
High | $33.40 | ||
Low | $31.33 | ||
Previous Close | $33.49 | ||
Volume | 42,061 | ||
30-Day Average Volume | 62,476 | ||
1-Week Change | -8.57% | ||
1-Month Change | -3.62% | ||
1-Year Change | 88.99% | ||
3-Year Change | 6.69% | ||
5-Year Change | -61.67% | ||
Fundamentals | |||
Shares Outstanding | 3.9M | ||
Total Assets | $98.8M | ||
Market Cap | $124.4M | ||
Enterprise Value | $26.3M | ||
Period: QTR TTM FY | |||
Revenue | $36.8M | ||
Net Income | $24.1M | ||
Free Cash Flow | $9.2M | ||
EBIT | $24.1M | ||
EBITDA | $24.1M | ||
Net Working Capital | $91.9M | ||
EPS | $1.65 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | 1 | ||
P/B | 1 | ||
P/E | 19 | ||
PEG | 0 | ||
Price/Free Cash Flow | 14 | ||
Price/Operating Cash Flow | 14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 40 | ||
Last Split Date | 11/21/2023 | ||
Earnings & Revenue